Status:

UNKNOWN

Sarcopenia and Risk of Fall in Osteoporotic Postmenopausal Women

Lead Sponsor:

I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio

Conditions:

Sarcopenia

Falls Patient

Eligibility:

FEMALE

60+ years

Phase:

NA

Brief Summary

The main scope of the present pilot study is to evaluate the possible association between the status of sarcopenia and the risk of fall in osteoporotic postmenopausal women. Forty osteoporotic postmen...

Detailed Description

A grave change associated with human ageing is progressive decline in skeletal muscle mass, a downward spiral that may lead to decreased strength and functionality. The term 'sarcopenia' (Greek 'sarx'...

Eligibility Criteria

Inclusion

  • Female.
  • Aged over 60 yo.
  • Classified as osteoporotic with t-score = or \< -2,5 evaluated by DXA.
  • Autonomous walking.
  • Signed informed consent.

Exclusion

  • Male.
  • Aged under 60 yo.
  • Psychiatric disorders.
  • Neurological pathologies.
  • Endocrine disorders.
  • Active cigarettes smoke.
  • Recent bone fractures (6 months)
  • Surgical treatments for orthopedic pathologies (6 months).
  • Pacemaker carrier.
  • Use of drugs influencing bone metabolism or limiting physical function.

Key Trial Info

Start Date :

March 29 2017

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 31 2019

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT03382366

Start Date

March 29 2017

End Date

May 31 2019

Last Update

July 17 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

IRCCS Istituto Ortopedico Galeazzi

Milan, Italy, 20161